Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VAX014 |
Trade Name | |
Synonyms | VAX-IP|VAX 014|VAX-014 |
Drug Descriptions |
VAX014 is bacterial minicell therapeutic comprising E. coli engineered to express Invasin and the bacterial toxin perfringolysin O (PFO), which delivers the toxin to tumor cells expressing Integrin alpha3beta1 or alpha5beta1, potentially resulting in increased tumor cell apoptosis and decreased tumor growth (PMID: 27919942, PMID: 27119118). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C170742 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
VAX014 | VAX014 | 0 | 2 |